Abstract This series builds on the earlier segments, bringing together a rich mix of engaging case-based discussions, expert-led panels on infections in immunocompromised hosts, and updates from recent high-impact literature in infectious diseases. The instalment highlights key themes including nuanced diagnostic reasoning, advances in therapeutic drug monitoring, and the application of emerging evidence to complex, real-world clinical scenarios. The sessions reflect the growing need for precision-guided, individualized care in modern infectious diseases practice, particularly in high-risk populations. As the concluding part of the three-part series, this section curated by dedicated rapporteurs consolidates the most impactful clinical pearls and contemporary insights from CIDSCON 2025, translating them into practical knowledge for everyday clinical practice.
Ramabhadran et al. (2026) studied this question.